Present in Morocco since 2015, Cipla’s added value to the Moroccan healthcare landscape was quickly noticeable, by the inauguration of the country’s first inhalers manufacturing unit, responding to the need of millions of Moroccans to respiratory products access.

Cipla Morocco current focus is made on two therapeutic segments. Respiratory products covering asthma, COPD and allergic rhinitis, and CNS products treating depression, schizophrenia and bipolar disoder. With an important pipeline of products that are under registration, Cipla Morocco aims to enrich healthcare professionals therapeutic arsenal, and mainly, promote access to as many people as possible to high quality products, regardless of where they live or how much they earn.